Literature DB >> 17909317

Early virologic rebound in a pilot trial of ritonavir-boosted atanazavir as maintenance monotherapy.

Jose R Arribas, Federico Pulido.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17909317     DOI： 10.1097/QAI.0b013e318061b780

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN： 1525-4135            Impact factor:   3.731


× No keyword cloud information.
  2 in total

1.  Single genome sequencing of HIV-1 gag and protease resistance mutations at virologic failure during the OK04 trial of simplified versus standard maintenance therapy.

Authors:  John E McKinnon; Rafael Delgado; Federico Pulido; Wei Shao; Jose R Arribas; John W Mellors
Journal:  Antivir Ther       Date:  2011

2.  A Multicenter, Open Labeled, Randomized, Phase III Study Comparing Lopinavir/Ritonavir Plus Atazanavir to Lopinavir/Ritonavir Plus Zidovudine and Lamivudine in Naive HIV-1-Infected Patients: 48-Week Analysis of the LORAN Trial.

Authors:  K U Ulbricht; G M Behrens; M Stoll; B Salzberger; H Jessen; A B Jessen; B Kuhlmann; H Heiken; A Trein; R E Schmidt
Journal:  Open AIDS J       Date:  2011-04-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.